Listen as Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, review strategies for more expansive HBV treatment while considering adverse events, cost-effectiveness, and patient perspectives.
Published 03/26/24
Listen as Douglas Dieterich, MD; Camilla S. Graham, MD, MPH; and Robert Wong, MD, MS, review barriers to and strategies for adopting new recommendations on universal HBV screening for all adults and best practices for screening of all patients with chronic HBV infection for HDV in the United States.
Published 12/22/23